Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
CognifiSense develops Virtual Reality Neuropsychological Therapy (VRNT), an immersive VR program that retrains the brain's pain pathways to reduce chronic pain without medication or invasive treatments. It serves patients experiencing chronic pain and the healthcare providers who treat them.
2 investors
Cognito is a Canadian online mental health service offering cognitive behavioral therapy and psychiatric care for anxiety, depression, insomnia, and ADHD. The service operates virtually across British Columbia and Ontario, serving residents aged 17 and older.
2 investors
Cognito Therapeutics develops Spectris, a non-invasive sensory stimulation technology platform to treat neurodegenerative diseases including Alzheimer's by improving cognitive performance. The company serves patients with neurodegenerative conditions and aims to transform disease management through clinical-to-commercial pathways in the neurological therapeutics sector.
2 investors
Cognotion develops immersive digital training programs for frontline healthcare workers, using storytelling, simulations, and interactive modules to improve patient care and workforce readiness. The platform helps healthcare institutions train staff in areas such as dementia care, clinical skills, and communication.
2 investors
Colorescience is a professional skincare brand that develops mineral-based sun protection (SPF), skincare, and color correction products, originally created for post-procedure skin and marketed for all ages and skin types. Its SPF products use only 100% mineral active ingredients such as zinc oxide and titanium dioxide.
2 investors
Coloursmith develops precision light-filtering ingredients for contact lenses using patented chromophore encapsulation technology, enabling lens manufacturers to create products with improved light protection and comfort.
2 investors
Colospan develops the CG-100, an internal bypass medical device for colorectal surgery that provides an alternative to stoma pouches. The company serves surgeons and patients requiring colorectal procedures in the medtech sector.
2 investors
Combat is a clinical-stage cancer treatment company focused on developing therapies for bladder and prostate cancer. The company is advised by leading urologic surgeons and oncologists specializing in robotic surgery and immunotherapy approaches.
2 investors
CombineHealth AI builds AI agents that automate complex workflows across the healthcare revenue cycle, helping healthcare providers reduce manual work, improve collections, and accelerate cash flow.
2 investors
Compassus is a home health and hospice care provider serving community-based healthcare organizations in the United States.
2 investors
Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration. A University of Manchester spinout, it runs clinical and natural history studies in ophthalmology across the US and UK.
2 investors
CompliantRx offers AI-powered software that helps durable medical equipment (DME) suppliers manage documentation and compliance, flagging gaps and generating addendum requests to keep insurance claims moving. It targets DME providers of all sizes, from small teams to high-volume enterprises, in the healthcare compliance category.
2 investors
CPS Solutions provides pharmacy management services to hospitals and health systems, including specialty pharmacy, 24/7 telepharmacy support (remote order entry and verification, transitions of care), 340B compliance, rehabilitation, and materials management. It serves over 800 healthcare customers across the US and Puerto Rico.
2 investors
Concha Labs makes Concha Sol, an FDA-cleared over-the-counter self-fitting hearing aid that uses patented technology to personalize a user's sound profile, with a focus on hearing speech in noisy environments. The devices are aimed at individuals with mild-to-moderate hearing loss and are set up at home.
2 investors
CoNextions Medical develops implantable devices for orthopaedic soft tissue repair, including systems for tendon repair and soft tissue-to-bone fixation intended for use by surgeons. Its implants are designed to replace or improve on conventional suture-based repair methods.
2 investors
2 investors
Confrere offers a browser-based video calling service where professionals such as physicians, consultants, and tutors meet clients over video via a personalized link (YOURBRAND.confrere.com). It includes a virtual waiting room where visitors check in and wait to be called from the professional's dashboard, supporting back-to-back meetings.
2 investors
Connect Biopharma is a clinical-stage biopharmaceutical company developing antibody-based therapies targeting inflammatory diseases such as atopic dermatitis and asthma. The company operates globally with headquarters in San Diego and operations in the U.S. and China.
2 investors
2 investors
ConnectiveRx provides hub services, patient support, and patient affordability programs that help pharmaceutical manufacturers, healthcare providers, and patients access and stay on prescribed therapies. It offers point-of-care awareness and adherence messaging as a single-partner solution for medication access in the pharmaceutical industry.
2 investors
ConnectureDRX provides Medicare enrollment and drug transparency technology for health plans, agents, and consumers. The company offers analytics and data-driven solutions to help healthcare organizations engage members and navigate Medicare complexities.
2 investors
Connie Health helps older Americans choose and navigate Medicare plans by combining technology with local licensed agents, providing unbiased plan recommendations and an ongoing local care team at no cost to the user. It operates in the US health insurance and Medicare advisory space, focused on the senior/Medicare-eligible market.
2 investors
Constellation develops foundation models of human state aimed at understanding brains, bodies, and environments. The company works across AI research, data science, software engineering, and hardware engineering.
2 investors
Context Therapeutics develops clinical-stage T cell engaging bispecific antibody therapies for the treatment of solid tumors. Its pipeline targets antigens such as Claudin 6, mesothelin, and Nectin-4 to direct the immune system against difficult-to-treat cancers.
2 investors